| Financial Year |
March 31 2023 |
| Monetary Funds |
383,518,102.77 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
3,500,000.00 |
| Accounts Receivable |
451,680,639.04 |
| Advances to Suppliers |
39,459,797.27 |
| Other Receivables |
13,034,531.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,066,398,394.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,277,249.76 |
| Other Current Assets |
5,841,644.62 |
| Total Current Assets |
2,032,383,669.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,607,815.60 |
| Long-term Equity Investment |
50,848,343.59 |
| Investment Properties |
-- |
| Fixed Assetes |
345,481,715.39 |
| Under-construction Projects |
65,662,334.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
76,748,054.07 |
| R&D expenses |
-- |
| Goodwill |
45,805,637.40 |
| Long-Term Deferred and Prepaid Expenses |
8,469,389.54 |
| Deferred Income Tax Assets |
22,059,437.52 |
| Other Non-Current Assets |
5,187,755.89 |
| Sub-Total of Non-Current Assets |
637,300,375.82 |
| Total Assets |
2,669,684,045.72 |
| Short-Term Loans |
170,371,145.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
44,583,006.91 |
| Accounts Payable |
251,963,051.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,050,817.63 |
| Taxes Payable |
5,722,868.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,372,373.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,633,405.37 |
| Other Current Liabilities |
48,647,146.49 |
| Sub-Total of Current Liabilities |
934,804,762.86 |
| Long-term Loans |
72,649,845.35 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
18,908,982.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,410.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
103,375,711.72 |
| Total Liabilities |
1,038,180,474.58 |
| Paid-In Capital(Or Share Stock) |
410,977,250.00 |
| Capital Surplus |
467,236,800.73 |
| Surplus Reserve |
142,874,536.34 |
| LESS:Treasury Stock |
58,910,014.00 |
| Undistributed Profits |
651,887,266.64 |
| Minority Stockholder's Interest |
6,543,711.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,624,959,859.28 |
| Owner's Equity（Stockholder's Equity） |
1,631,503,571.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,669,684,045.72 |
